224 related articles for article (PubMed ID: 10565845)
1. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat.
Rivière GJ; Byrnes KA; Gentry WB; Owens SM
J Pharmacol Exp Ther; 1999 Dec; 291(3):1220-6. PubMed ID: 10565845
[TBL] [Abstract][Full Text] [Related]
2. Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats.
Milesi-Hallé A; Hendrickson HP; Laurenzana EM; Gentry WB; Owens SM
Toxicol Appl Pharmacol; 2005 Dec; 209(3):203-13. PubMed ID: 15916788
[TBL] [Abstract][Full Text] [Related]
3. Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration.
Rivière GJ; Gentry WB; Owens SM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1042-7. PubMed ID: 10688621
[TBL] [Abstract][Full Text] [Related]
4. (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration.
Gentry WB; Ghafoor AU; Wessinger WD; Laurenzana EM; Hendrickson HP; Owens SM
Pharmacol Biochem Behav; 2004 Dec; 79(4):751-60. PubMed ID: 15582684
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats.
Gentry WB; Laurenzana EM; Williams DK; West JR; Berg RJ; Terlea T; Owens SM
Int Immunopharmacol; 2006 Jun; 6(6):968-77. PubMed ID: 16644483
[TBL] [Abstract][Full Text] [Related]
6. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
[TBL] [Abstract][Full Text] [Related]
7. Human pharmacology of the methamphetamine stereoisomers.
Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
[TBL] [Abstract][Full Text] [Related]
8. Gestation time-dependent pharmacokinetics of intravenous (+)-methamphetamine in rats.
White S; Laurenzana E; Hendrickson H; Gentry WB; Owens SM
Drug Metab Dispos; 2011 Sep; 39(9):1718-26. PubMed ID: 21632964
[TBL] [Abstract][Full Text] [Related]
9. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization.
Segal DS; Kuczenski R
J Pharmacol Exp Ther; 1997 Aug; 282(2):561-73. PubMed ID: 9262316
[TBL] [Abstract][Full Text] [Related]
10. Development of a home cage locomotor tracking system capable of detecting the stimulant and sedative properties of drugs in rats.
Dunne F; O'Halloran A; Kelly JP
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1456-63. PubMed ID: 17706334
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain.
Wang JQ; McGinty JF
J Pharmacol Exp Ther; 1995 May; 273(2):909-17. PubMed ID: 7752096
[TBL] [Abstract][Full Text] [Related]
12. Development of a liquid chromatography-tandem mass spectrometric method for the determination of methamphetamine and amphetamine using small volumes of rat serum.
Hendrickson HP; Milesi-Hallé A; Laurenzana EM; Owens SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):81-7. PubMed ID: 15171915
[TBL] [Abstract][Full Text] [Related]
13. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
Cho AK; Melega WP; Kuczenski R; Segal DS
Synapse; 2001 Feb; 39(2):161-6. PubMed ID: 11180503
[TBL] [Abstract][Full Text] [Related]
14. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat.
Edgar DM; Seidel WF
J Pharmacol Exp Ther; 1997 Nov; 283(2):757-69. PubMed ID: 9353396
[TBL] [Abstract][Full Text] [Related]
15. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague-Dawley rats.
Milesi-Hallé A; McMillan DE; Laurenzana EM; Byrnes-Blake KA; Owens SM
Pharmacol Biochem Behav; 2007 Jan; 86(1):140-9. PubMed ID: 17275894
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological effects of two anti-methamphetamine monoclonal antibodies. Supporting data for lead candidate selection for clinical development.
Laurenzana EM; Stevens MW; Frank JC; Hambuchen MD; Hendrickson HP; White SJ; Williams DK; Owens SM; Gentry WB
Hum Vaccin Immunother; 2014; 10(9):2638-47. PubMed ID: 25483484
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine decreases calcium-calmodulin dependent protein kinase II activity in discrete rat brain regions.
Suemaru J; Akiyama K; Tanabe Y; Kuroda S
Synapse; 2000 Jun; 36(3):155-66. PubMed ID: 10819896
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling.
Melega WP; Cho AK; Harvey D; Laćan G
Synapse; 2007 Apr; 61(4):216-20. PubMed ID: 17230548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
